. (CBYL)
$0 0 (0.00%)
Market Cap: $0
As of 12/31/69 07:00 PM EST. Market closed.
. (CBYL)
$0 0 (0.00%)
Market Cap: $0
As of 12/31/69 07:00 PM EST. Market closed.
COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
URL
Address
.
PRICE CHART
From:
To:
NEWS
KEY STATS
Open
$0
Previous Close
$0
Days Range
$0 - $0
52 week range
$0 - $0
Volume
0
Avg. Volume (30 days)
0
Market Cap
$0
Dividend Yield
0.00%
P/E
-
Shares Outstanding
0
Open
$0
Previous Close
$0
Days Range
$0 - $0
52 week range
$0 - $0
Volume
0
Avg. Volume (30 days)
0
Market Cap
$0
Dividend Yield
0.00%
P/E
-
Shares Outstanding
0
Open in:
Open in:
INSIDER TRANSACTIONS FOR
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Crockett Thomas Andrew | CEO | Mar 09, 2022 | Sale | $17.07 | 10,000 | 170,693 | 114,670 | Mar 11, 2022, 04:56 PM |
| Feener Edward P. | Chief Scientific Officer | Jan 07, 2022 | Option Exercise | $7.54 | 57,657 | 434,832 | 59,891 | Jan 11, 2022, 04:42 PM |
| Feener Edward P. | Chief Scientific Officer | Nov 01, 2021 | Sale | $18.07 | 6,000 | 108,424 | 2,234 | Nov 03, 2021, 05:00 PM |
| Yea Christopher | Chief Development Officer | Nov 01, 2021 | Sale | $18.07 | 5,000 | 90,328 | 32,969 | Nov 03, 2021, 04:56 PM |
| Crockett Thomas Andrew | CEO | Oct 01, 2021 | Sale | $17.18 | 10,000 | 171,841 | 124,670 | Oct 04, 2021, 04:57 PM |
| Yea Christopher | Chief Development Officer | Aug 02, 2021 | Sale | $20.52 | 5,000 | 102,578 | 37,969 | Aug 04, 2021, 07:55 PM |
| Feener Edward P. | Chief Scientific Officer | Aug 02, 2021 | Sale | $20.52 | 6,000 | 123,134 | 8,234 | Aug 04, 2021, 07:55 PM |
| Crockett Thomas Andrew | CEO | Jul 01, 2021 | Sale | $24.15 | 10,000 | 241,477 | 140,320 | Jul 02, 2021, 05:35 PM |
| Crockett Thomas Andrew | CEO | Jun 09, 2021 | Sale | $30.05 | 8,933 | 268,480 | 145,737 | Jun 11, 2021, 07:29 PM |
| Smith Michael David | Senior VP, Development | Jun 01, 2021 | Option Exercise | $8.39 | 7,500 | 62,925 | 7,500 | Jun 03, 2021, 06:28 PM |
| Smith Michael David | Senior VP, Development | Jun 01, 2021 | Sale | $26.83 | 7,500 | 201,221 | 0 | Jun 03, 2021, 06:28 PM |
| Feener Edward P. | Chief Scientific Officer | Jun 02, 2021 | Sale | $26.43 | 8,200 | 216,696 | 15,296 | Jun 03, 2021, 06:26 PM |
| Feener Edward P. | Chief Scientific Officer | Jun 01, 2021 | Sale | $26.81 | 25,800 | 691,665 | 22,448 | Jun 03, 2021, 06:26 PM |
| Feener Edward P. | Chief Scientific Officer | May 03, 2021 | Option Exercise | $10.21 | 6,000 | 61,260 | 60,234 | May 06, 2021, 08:03 PM |
| Feener Edward P. | Chief Scientific Officer | May 03, 2021 | Sale | $24.84 | 6,000 | 149,051 | 54,234 | May 06, 2021, 08:03 PM |
| Smith Michael David | Senior VP, Development | Apr 28, 2021 | Option Exercise | $8.39 | 10,014 | 84,017 | 10,014 | Apr 30, 2021, 05:49 PM |
| Smith Michael David | Senior VP, Development | Apr 28, 2021 | Sale | $25.76 | 10,014 | 257,983 | 0 | Apr 30, 2021, 05:49 PM |
| Maetzel Andreas | Senior Vice President, Medical | Apr 27, 2021 | Option Exercise | $7.91 | 11,017 | 87,144 | 11,017 | Apr 29, 2021, 08:55 PM |
| Maetzel Andreas | Senior Vice President, Medical | Apr 29, 2021 | Option Exercise | $10.69 | 40,886 | 437,023 | 40,886 | Apr 29, 2021, 08:55 PM |
| Maetzel Andreas | Senior Vice President, Medical | Apr 28, 2021 | Option Exercise | $7.91 | 36,127 | 285,765 | 36,127 | Apr 29, 2021, 08:55 PM |
| Maetzel Andreas | Senior Vice President, Medical | Apr 29, 2021 | Sale | $25.04 | 40,886 | 1,023,589 | 0 | Apr 29, 2021, 08:55 PM |
| Maetzel Andreas | Senior Vice President, Medical | Apr 28, 2021 | Sale | $25.41 | 36,127 | 917,985 | 25,507 | Apr 29, 2021, 08:55 PM |
| Maetzel Andreas | Senior Vice President, Medical | Apr 27, 2021 | Sale | $25.79 | 11,017 | 284,163 | 0 | Apr 29, 2021, 08:55 PM |
| Crockett Thomas Andrew | CEO | Apr 01, 2021 | Sale | $27.44 | 10,000 | 274,436 | 168,720 | Apr 05, 2021, 06:38 PM |
| Yea Christopher | Chief Development Officer | Feb 23, 2021 | Sale | $33.59 | 15,000 | 503,877 | 62,169 | Feb 25, 2021, 08:25 PM |
| Palleiko Benjamin L | CFO, CBO & Secretary | Feb 23, 2021 | Option Exercise | $6.74 | 29,642 | 199,787 | 94,642 | Feb 25, 2021, 08:23 PM |
| Palleiko Benjamin L | CFO, CBO & Secretary | Feb 23, 2021 | Sale | $33.59 | 29,642 | 995,562 | 93,642 | Feb 25, 2021, 08:23 PM |
| Feener Edward P. | Chief Scientific Officer | Feb 23, 2021 | Sale | $33.60 | 31,000 | 1,041,642 | 83,946 | Feb 25, 2021, 08:22 PM |
| Crockett Thomas Andrew | CEO | Feb 23, 2021 | Sale | $33.55 | 10,000 | 335,538 | 178,920 | Feb 25, 2021, 08:20 PM |
| Crockett Thomas Andrew | CEO | Jan 04, 2021 | Sale | $18.19 | 10,000 | 181,904 | 186,234 | Jan 06, 2021, 05:33 PM |
| Palleiko Benjamin L | CFO, CBO & Secretary | Dec 30, 2020 | Option Exercise | $6.74 | 358 | 2,413 | 32,858 | Jan 04, 2021, 06:06 PM |
| Palleiko Benjamin L | CFO, CBO & Secretary | Dec 30, 2020 | Sale | $20.04 | 358 | 7,175 | 32,500 | Jan 04, 2021, 06:06 PM |
| Feener Edward P. | Chief Scientific Officer | Nov 02, 2020 | Sale | $17.14 | 6,000 | 102,812 | 72,734 | Nov 04, 2020, 05:03 PM |
| Cha Albert | Director | Oct 30, 2020 | Buy | $17.24 | 115,686 | 1,994,068 | 1,138,179 | Nov 03, 2020, 07:56 PM |
| Yea Christopher | Chief Development Officer | Oct 29, 2020 | Sale | $17.48 | 5,000 | 87,394 | 62,969 | Nov 02, 2020, 08:01 PM |
| Yea Christopher | Chief Development Officer | Oct 21, 2020 | Sale | $18.25 | 6,044 | 110,282 | 70,513 | Oct 22, 2020, 05:36 PM |
| Yea Christopher | Chief Development Officer | Oct 20, 2020 | Sale | $17.49 | 7,942 | 138,886 | 76,315 | Oct 22, 2020, 05:36 PM |
| Feener Edward P. | Chief Scientific Officer | Oct 20, 2020 | Sale | $17.48 | 7,900 | 138,090 | 90,041 | Oct 22, 2020, 05:34 PM |
| Feener Edward P. | Chief Scientific Officer | Oct 21, 2020 | Sale | $18.31 | 9,007 | 164,928 | 84,141 | Oct 22, 2020, 05:34 PM |
| Crockett Thomas Andrew | CEO | Oct 21, 2020 | Sale | $18.33 | 22,545 | 413,247 | 212,165 | Oct 22, 2020, 05:33 PM |
| Crockett Thomas Andrew | CEO | Oct 20, 2020 | Sale | $17.49 | 15,994 | 279,778 | 222,741 | Oct 22, 2020, 05:33 PM |
| Yea Christopher | Chief Development Officer | Oct 16, 2020 | Sale | $17.00 | 914 | 15,539 | 81,955 | Oct 20, 2020, 02:14 PM |
| Feener Edward P. | Chief Scientific Officer | Oct 16, 2020 | Sale | $17.00 | 993 | 16,881 | 95,641 | Oct 20, 2020, 02:11 PM |
| Crockett Thomas Andrew | CEO | Oct 16, 2020 | Sale | $17.01 | 1,261 | 21,444 | 236,959 | Oct 20, 2020, 02:08 PM |
| Yea Christopher | Chief Development Officer | Feb 05, 2020 | Sale | $17.10 | 100 | 1,710 | 82,869 | Feb 07, 2020, 05:18 PM |
| Feener Edward P. | Chief Scientific Officer | Feb 05, 2020 | Sale | $17.11 | 100 | 1,711 | 96,634 | Feb 07, 2020, 05:17 PM |
| Crockett Thomas Andrew | CEO | Feb 05, 2020 | Sale | $17.05 | 200 | 3,410 | 238,220 | Feb 07, 2020, 05:14 PM |
| Yea Christopher | Chief Development Officer | Dec 20, 2019 | Option Exercise | $0.00 | 2,646 | 11 | 85,615 | Dec 26, 2019, 05:32 PM |
| Yea Christopher | Chief Development Officer | Dec 20, 2019 | Sale | $17.02 | 2,646 | 45,025 | 82,969 | Dec 26, 2019, 05:32 PM |
| Crockett Thomas Andrew | CEO | Dec 20, 2019 | Sale | $17.02 | 2,300 | 39,150 | 238,420 | Dec 26, 2019, 05:30 PM |
| Yea Christopher | Chief Development Officer | Dec 12, 2019 | Option Exercise | $0.00 | 199 | 1 | 83,168 | Dec 16, 2019, 07:34 PM |
| Yea Christopher | Chief Development Officer | Dec 16, 2019 | Option Exercise | $0.00 | 3,010 | 13 | 85,979 | Dec 16, 2019, 07:34 PM |
| Yea Christopher | Chief Development Officer | Dec 13, 2019 | Option Exercise | $0.00 | 1,500 | 6 | 84,469 | Dec 16, 2019, 07:34 PM |
| Yea Christopher | Chief Development Officer | Dec 12, 2019 | Sale | $17.00 | 199 | 3,383 | 82,969 | Dec 16, 2019, 07:34 PM |
| Yea Christopher | Chief Development Officer | Dec 16, 2019 | Sale | $17.05 | 3,010 | 51,318 | 82,969 | Dec 16, 2019, 07:34 PM |
| Yea Christopher | Chief Development Officer | Dec 13, 2019 | Sale | $17.05 | 1,500 | 25,568 | 82,969 | Dec 16, 2019, 07:34 PM |
| Crockett Thomas Andrew | CEO | Dec 16, 2019 | Sale | $17.06 | 5,400 | 92,116 | 240,720 | Dec 16, 2019, 07:32 PM |
| Crockett Thomas Andrew | CEO | Dec 13, 2019 | Sale | $17.06 | 2,200 | 37,536 | 246,120 | Dec 16, 2019, 07:32 PM |
| Crockett Thomas Andrew | CEO | Dec 12, 2019 | Sale | $17.00 | 100 | 1,700 | 248,320 | Dec 16, 2019, 07:32 PM |
| SOLAND DANIEL B | Director | Sep 27, 2019 | Buy | $11.87 | 7,962 | 94,498 | 10,000 | Sep 30, 2019, 05:23 PM |
| SOLAND DANIEL B | Director | Sep 26, 2019 | Buy | $11.90 | 2,038 | 24,252 | 2,038 | Sep 30, 2019, 05:23 PM |
| Cha Albert | Director | Jul 29, 2019 | Buy | $17.13 | 5,137 | 88,011 | 124,566 | Jul 30, 2019, 07:37 PM |
| Cha Albert | Director | Jul 29, 2019 | Buy | $17.13 | 24,730 | 423,692 | 1,022,493 | Jul 30, 2019, 07:37 PM |
| Cha Albert | Director | Jul 26, 2019 | Buy | $16.83 | 21,942 | 369,317 | 997,763 | Jul 30, 2019, 07:37 PM |
| Cha Albert | Director | Jul 26, 2019 | Buy | $16.83 | 4,558 | 76,718 | 119,429 | Jul 30, 2019, 07:37 PM |
| Yea Christopher | Chief Development Officer | Jul 22, 2019 | Option Exercise | $0.00 | 7,355 | 32 | 90,324 | Jul 24, 2019, 05:53 PM |
| Yea Christopher | Chief Development Officer | Jul 22, 2019 | Sale | $18.35 | 7,355 | 134,930 | 82,969 | Jul 24, 2019, 05:53 PM |
| Feener Edward P. | Chief Scientific Officer | Jul 23, 2019 | Sale | $18.65 | 1,900 | 35,439 | 96,734 | Jul 24, 2019, 05:52 PM |
| Feener Edward P. | Chief Scientific Officer | Jul 22, 2019 | Sale | $18.57 | 1,400 | 26,004 | 98,634 | Jul 24, 2019, 05:52 PM |
| Cha Albert | Director | Jul 19, 2019 | Buy | $17.68 | 10,320 | 182,453 | 114,871 | Jul 19, 2019, 06:38 PM |
| Cha Albert | Director | Jul 17, 2019 | Buy | $16.93 | 220 | 3,724 | 104,551 | Jul 19, 2019, 06:38 PM |
| Cha Albert | Director | Jul 17, 2019 | Buy | $16.97 | 1,060 | 17,991 | 926,141 | Jul 19, 2019, 06:38 PM |
| Cha Albert | Director | Jul 19, 2019 | Buy | $17.84 | 49,680 | 886,127 | 975,821 | Jul 19, 2019, 06:38 PM |
| Crockett Thomas Andrew | CEO | Jul 15, 2019 | Sale | $17.04 | 10,000 | 170,407 | 248,510 | Jul 17, 2019, 06:52 PM |
| Yea Christopher | Chief Development Officer | Apr 22, 2019 | Option Exercise | $0.00 | 7,355 | 32 | 90,324 | Apr 23, 2019, 05:33 PM |
| Yea Christopher | Chief Development Officer | Apr 22, 2019 | Sale | $26.04 | 7,355 | 191,530 | 83,969 | Apr 23, 2019, 05:33 PM |
| Crockett Thomas Andrew | CEO | Apr 15, 2019 | Sale | $24.80 | 10,000 | 247,958 | 258,810 | Apr 23, 2019, 05:30 PM |
| Palleiko Benjamin L | CBO, CFO and Secretary | Apr 22, 2019 | Option Exercise | $8.39 | 2,000 | 16,780 | 34,500 | Apr 22, 2019, 05:58 PM |
| Palleiko Benjamin L | CBO, CFO and Secretary | Apr 18, 2019 | Option Exercise | $6.74 | 1,073 | 7,232 | 33,573 | Apr 22, 2019, 05:58 PM |
| Palleiko Benjamin L | CBO, CFO and Secretary | Apr 22, 2019 | Sale | $25.80 | 2,000 | 51,603 | 32,500 | Apr 22, 2019, 05:58 PM |
| Palleiko Benjamin L | CBO, CFO and Secretary | Apr 18, 2019 | Sale | $25.51 | 1,073 | 27,373 | 32,500 | Apr 22, 2019, 05:58 PM |
| Feener Edward P. | Chief Scientific Officer | Apr 17, 2019 | Sale | $24.92 | 4,000 | 99,666 | 100,950 | Apr 18, 2019, 06:30 PM |
| SVLSF IV, LLC | 10% Owner | Apr 10, 2019 | Sale | $29.40 | 13,531 | 397,746 | 1,672,105 | Apr 10, 2019, 07:21 PM |
| SVLSF IV, LLC | 10% Owner | Apr 09, 2019 | Sale | $28.53 | 13,669 | 389,983 | 1,685,262 | Apr 10, 2019, 07:21 PM |
| SVLSF IV, LLC | 10% Owner | Apr 08, 2019 | Sale | $29.49 | 22,800 | 672,415 | 1,698,554 | Apr 10, 2019, 07:21 PM |
| Maetzel Andreas | Senior Vice President Medical | Apr 05, 2019 | Option Exercise | $7.91 | 5,000 | 39,550 | 5,000 | Apr 09, 2019, 05:33 PM |
| Maetzel Andreas | Senior Vice President Medical | Apr 05, 2019 | Sale | $30.00 | 5,000 | 150,011 | 0 | Apr 09, 2019, 05:33 PM |
| SVLSF IV, LLC | 10% Owner | Apr 02, 2019 | Sale | $28.76 | 9,141 | 262,930 | 1,720,725 | Apr 02, 2019, 06:57 PM |
| SVLSF IV, LLC | 10% Owner | Apr 01, 2019 | Sale | $27.66 | 52,831 | 1,461,210 | 1,729,613 | Apr 02, 2019, 06:57 PM |
| SVLSF IV, LLC | 10% Owner | Mar 29, 2019 | Sale | $28.40 | 35,102 | 996,756 | 1,780,986 | Apr 02, 2019, 06:57 PM |
| SVLSF IV, LLC | 10% Owner | Mar 27, 2019 | Sale | $29.06 | 57,917 | 1,683,022 | 1,850,772 | Mar 28, 2019, 05:29 PM |
| SVLSF IV, LLC | 10% Owner | Mar 26, 2019 | Sale | $29.70 | 30,093 | 893,687 | 1,907,090 | Mar 28, 2019, 05:29 PM |
| SVLSF IV, LLC | 10% Owner | Mar 28, 2019 | Sale | $27.80 | 36,665 | 1,019,324 | 1,815,119 | Mar 28, 2019, 05:29 PM |
| SVLSF IV, LLC | 10% Owner | Mar 18, 2019 | Sale | $26.70 | 262,470 | 7,007,949 | 1,936,352 | Mar 20, 2019, 04:13 PM |
| Venrock Healthcare Capital Partners II, L.P. | 10% Owner | Mar 18, 2019 | Sale | $28.75 | 500,000 | 14,375,000 | 1,544,112 | Mar 20, 2019, 04:08 PM |
| Crockett Thomas Andrew | CEO | Mar 14, 2019 | Sale | $30.16 | 3,000 | 90,484 | 268,510 | Mar 15, 2019, 08:03 PM |
| SVLSF IV, LLC | 10% Owner | Mar 04, 2019 | Sale | $22.91 | 43,378 | 993,660 | 2,223,015 | Mar 06, 2019, 09:05 AM |
| SVLSF IV, LLC | 10% Owner | Mar 05, 2019 | Sale | $23.04 | 32,332 | 744,816 | 2,191,576 | Mar 06, 2019, 09:05 AM |
| SVLSF IV, LLC | 10% Owner | Feb 21, 2019 | Sale | $20.60 | 172,543 | 3,554,386 | 2,265,196 | Feb 21, 2019, 02:35 PM |
| SVLSF IV, LLC | 10% Owner | Feb 20, 2019 | Sale | $20.02 | 23,235 | 465,069 | 2,432,975 | Feb 21, 2019, 02:35 PM |
| SVLSF IV, LLC | 10% Owner | Feb 19, 2019 | Sale | $20.73 | 18,420 | 381,898 | 2,455,569 | Feb 21, 2019, 02:35 PM |
| Yea Christopher | Chief Development Officer | Jan 25, 2019 | Option Exercise | $0.00 | 5,453 | 23 | 88,422 | Jan 29, 2019, 06:53 PM |
| Yea Christopher | Chief Development Officer | Jan 25, 2019 | Sale | $17.06 | 5,453 | 93,015 | 82,969 | Jan 29, 2019, 06:53 PM |
| Yea Christopher | Chief Development Officer | Jan 23, 2019 | Option Exercise | $0.00 | 600 | 3 | 83,569 | Jan 24, 2019, 07:48 PM |
| Yea Christopher | Chief Development Officer | Jan 22, 2019 | Option Exercise | $0.00 | 1,302 | 6 | 84,271 | Jan 24, 2019, 07:48 PM |
| Yea Christopher | Chief Development Officer | Jan 23, 2019 | Sale | $17.01 | 600 | 10,205 | 82,969 | Jan 24, 2019, 07:48 PM |
| Yea Christopher | Chief Development Officer | Jan 22, 2019 | Sale | $17.00 | 1,302 | 22,139 | 82,969 | Jan 24, 2019, 07:48 PM |
| Feener Edward P. | Chief Scientific Officer | Jan 16, 2019 | Sale | $19.55 | 4,000 | 78,210 | 106,334 | Jan 18, 2019, 05:42 PM |
| Crockett Thomas Andrew | CEO | Jan 14, 2019 | Sale | $19.33 | 10,000 | 193,328 | 272,411 | Jan 16, 2019, 06:25 PM |
| SVLSF IV, LLC | 10% Owner | Jan 07, 2019 | Sale | $20.41 | 2,599 | 53,051 | 2,473,481 | Jan 07, 2019, 05:12 PM |
| SVLSF IV, LLC | 10% Owner | Jan 03, 2019 | Sale | $20.01 | 1,700 | 34,022 | 2,476,008 | Jan 07, 2019, 05:12 PM |
| SVLSF IV, LLC | 10% Owner | Dec 28, 2018 | Sale | $20.03 | 3,734 | 74,781 | 2,502,571 | Jan 02, 2019, 07:10 PM |
| SVLSF IV, LLC | 10% Owner | Jan 02, 2019 | Sale | $20.00 | 200 | 4,000 | 2,477,661 | Jan 02, 2019, 07:10 PM |
| SVLSF IV, LLC | 10% Owner | Dec 31, 2018 | Sale | $20.00 | 25,418 | 508,462 | 2,477,855 | Jan 02, 2019, 07:10 PM |
| SVLSF IV, LLC | 10% Owner | Dec 19, 2018 | Sale | $20.02 | 2,136 | 42,758 | 2,506,202 | Dec 21, 2018, 04:19 PM |
| Feener Edward P. | Chief Scientific Officer | Sep 18, 2018 | Option Exercise | $17.05 | 2,500 | 42,625 | 108,034 | Sep 20, 2018, 07:33 PM |
| ORONSKY ARNOLD L | Director | Sep 10, 2018 | Buy | $17.00 | 58,824 | 1,000,008 | 388,766 | Sep 12, 2018, 12:00 AM |
| Cha Albert | Director | Sep 10, 2018 | Buy | $17.00 | 1,058,824 | 18,000,008 | 1,359,149 | Sep 12, 2018, 12:00 AM |
| ALDRICH RICHARD | Director | Oct 12, 2017 | Buy | $8.61 | 565,065 | 4,866,961 | 934,484 | Oct 19, 2017, 08:29 PM |
| RA CAPITAL MANAGEMENT, LLC | Director | Oct 12, 2017 | Buy | $8.50 | 850,000 | 7,225,000 | 1,441,070 | Oct 16, 2017, 04:32 PM |
| Shah Rajeev M. | Director | Oct 12, 2017 | Buy | $8.50 | 850,000 | 7,225,000 | 1,441,070 | Oct 16, 2017, 04:31 PM |
| Novo Holdings A/S | 10% Owner | Oct 10, 2017 | Sale | $11.66 | 963,283 | 11,232,599 | 2,311,927 | Oct 12, 2017, 05:21 PM |
| Novo Holdings A/S | 10% Owner | Oct 12, 2017 | Sale | $8.50 | 1,726,481 | 14,675,820 | 1,726,000 | Oct 12, 2017, 05:21 PM |
| Novo Holdings A/S | 10% Owner | Oct 11, 2017 | Sale | $10.21 | 35,519 | 362,763 | 1,726,481 | Oct 12, 2017, 05:21 PM |
| Novo Holdings A/S | 10% Owner | Sep 15, 2017 | Sale | $7.00 | 140,744 | 985,841 | 2,725,283 | Sep 18, 2017, 07:04 PM |
| Novo Holdings A/S | 10% Owner | Sep 14, 2017 | Sale | $8.05 | 10,000 | 80,500 | 2,866,027 | Sep 18, 2017, 07:04 PM |
| Novo Holdings A/S | 10% Owner | Sep 13, 2017 | Sale | $8.02 | 25,900 | 207,614 | 2,876,027 | Sep 18, 2017, 07:04 PM |
| Novo Holdings A/S | 10% Owner | Sep 13, 2017 | Sale | $8.02 | 25,900 | 207,614 | 2,876,027 | Sep 15, 2017, 07:18 PM |
| Novo Holdings A/S | 10% Owner | Sep 15, 2017 | Sale | $7.00 | 140,747 | 985,865 | 2,725,283 | Sep 15, 2017, 07:18 PM |
| Novo Holdings A/S | 10% Owner | Sep 14, 2017 | Sale | $8.05 | 10,000 | 80,500 | 2,866,027 | Sep 15, 2017, 07:18 PM |
| Renzi David | President & CEO | Nov 21, 2016 | Option Exercise | $8.59 | 33,454 | 287,477 | 3,186 | Nov 23, 2016, 01:35 PM |
| Renzi David | President & CEO | Nov 21, 2016 | Option Exercise | $7.84 | 36,640 | 287,258 | 36,640 | Nov 23, 2016, 01:35 PM |
| Renzi David | President & CEO | Nov 21, 2016 | Option Exercise | $8.59 | 3,186 | 27,378 | 0 | Nov 23, 2016, 01:35 PM |
| Basta Steven L | Director | Nov 21, 2016 | Option Exercise | $8.59 | 1,026 | 8,817 | 99 | Nov 22, 2016, 04:14 PM |
| Basta Steven L | Director | Nov 21, 2016 | Option Exercise | $7.84 | 1,125 | 8,820 | 1,125 | Nov 22, 2016, 04:14 PM |
| Basta Steven L | Director | Nov 21, 2016 | Option Exercise | $8.59 | 99 | 851 | 0 | Nov 22, 2016, 04:14 PM |
| Maroney Marcee | VP, Clinical Affairs | Nov 21, 2016 | Option Exercise | $8.59 | 4,255 | 36,564 | 409 | Nov 22, 2016, 04:13 PM |
| Maroney Marcee | VP, Clinical Affairs | Nov 21, 2016 | Option Exercise | $7.84 | 4,664 | 36,566 | 4,664 | Nov 22, 2016, 04:13 PM |
| Maroney Marcee | VP, Clinical Affairs | Nov 21, 2016 | Option Exercise | $8.59 | 409 | 3,515 | 0 | Nov 22, 2016, 04:13 PM |
| Renzi David | President & CEO | Dec 30, 2015 | Option Exercise | $0.56 | 10,000 | 5,600 | 10,000 | Dec 31, 2015, 04:05 PM |
| Renzi David | President & CEO | Dec 30, 2015 | Sale | $3.70 | 10,000 | 37,000 | 0 | Dec 31, 2015, 04:05 PM |
| CHA ALBERT | Director | Apr 14, 2015 | Buy | $5.00 | 1,012,500 | 5,062,500 | 4,204,562 | Apr 27, 2015, 02:40 PM |
| Vivo Ventures VI, LLC | 10% Owner | Apr 14, 2015 | Buy | $5.00 | 1,012,500 | 5,062,500 | 4,204,562 | Apr 24, 2015, 07:03 PM |
| InterWest Management Partners IX, LLC | 10% Owner | Apr 14, 2015 | Buy | $5.00 | 810,000 | 4,050,000 | 4,619,196 | Apr 14, 2015, 05:26 PM |
| ACMP IV LLC | 10% Owner | Apr 14, 2015 | Buy | $5.00 | 877,500 | 4,387,500 | 4,343,550 | Apr 14, 2015, 05:24 PM |
| NOHRA GUY P | Director | Apr 14, 2015 | Buy | $5.00 | 877,500 | 4,387,500 | 4,343,550 | Apr 14, 2015, 05:22 PM |
| CHA ALBERT | Director | Apr 14, 2015 | Buy | $5.00 | 1,012,500 | 5,062,500 | 4,204,564 | Apr 14, 2015, 05:22 PM |
| Vivo Ventures VI, LLC | 10% Owner | Apr 14, 2015 | Buy | $5.00 | 1,012,500 | 5,062,500 | 4,204,564 | Apr 14, 2015, 05:19 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Crockett Thomas Andrew | CEO | 03/09/2022 | 170,693 |
| Feener Edward P. | Chief Scientific Officer | 01/07/2022 | 434,832 |
| Feener Edward P. | Chief Scientific Officer | 11/01/2021 | 108,424 |
| Yea Christopher | Chief Development Officer | 11/01/2021 | 90,328 |
| Crockett Thomas Andrew | CEO | 10/01/2021 | 171,841 |
| Yea Christopher | Chief Development Officer | 08/02/2021 | 102,578 |
| Feener Edward P. | Chief Scientific Officer | 08/02/2021 | 123,134 |
| Crockett Thomas Andrew | CEO | 07/01/2021 | 241,477 |
| Crockett Thomas Andrew | CEO | 06/09/2021 | 268,480 |
| Smith Michael David | Senior VP, Development | 06/01/2021 | 62,925 |
| Smith Michael David | Senior VP, Development | 06/01/2021 | 201,221 |
| Feener Edward P. | Chief Scientific Officer | 06/02/2021 | 216,696 |
| Feener Edward P. | Chief Scientific Officer | 06/01/2021 | 691,665 |
| Feener Edward P. | Chief Scientific Officer | 05/03/2021 | 61,260 |
| Feener Edward P. | Chief Scientific Officer | 05/03/2021 | 149,051 |
| Smith Michael David | Senior VP, Development | 04/28/2021 | 84,017 |
| Smith Michael David | Senior VP, Development | 04/28/2021 | 257,983 |
| Maetzel Andreas | Senior Vice President, Medical | 04/27/2021 | 87,144 |
| Maetzel Andreas | Senior Vice President, Medical | 04/29/2021 | 437,023 |
| Maetzel Andreas | Senior Vice President, Medical | 04/28/2021 | 285,765 |
| Maetzel Andreas | Senior Vice President, Medical | 04/29/2021 | 1,023,589 |
| Maetzel Andreas | Senior Vice President, Medical | 04/28/2021 | 917,985 |
| Maetzel Andreas | Senior Vice President, Medical | 04/27/2021 | 284,163 |
| Crockett Thomas Andrew | CEO | 04/01/2021 | 274,436 |
| Yea Christopher | Chief Development Officer | 02/23/2021 | 503,877 |
| Palleiko Benjamin L | CFO, CBO & Secretary | 02/23/2021 | 199,787 |
| Palleiko Benjamin L | CFO, CBO & Secretary | 02/23/2021 | 995,562 |
| Feener Edward P. | Chief Scientific Officer | 02/23/2021 | 1,041,642 |
| Crockett Thomas Andrew | CEO | 02/23/2021 | 335,538 |
| Crockett Thomas Andrew | CEO | 01/04/2021 | 181,904 |
| Palleiko Benjamin L | CFO, CBO & Secretary | 12/30/2020 | 2,413 |
| Palleiko Benjamin L | CFO, CBO & Secretary | 12/30/2020 | 7,175 |
| Feener Edward P. | Chief Scientific Officer | 11/02/2020 | 102,812 |
| Cha Albert | Director | 10/30/2020 | 1,994,068 |
| Yea Christopher | Chief Development Officer | 10/29/2020 | 87,394 |
| Yea Christopher | Chief Development Officer | 10/21/2020 | 110,282 |
| Yea Christopher | Chief Development Officer | 10/20/2020 | 138,886 |
| Feener Edward P. | Chief Scientific Officer | 10/20/2020 | 138,090 |
| Feener Edward P. | Chief Scientific Officer | 10/21/2020 | 164,928 |
| Crockett Thomas Andrew | CEO | 10/21/2020 | 413,247 |
| Crockett Thomas Andrew | CEO | 10/20/2020 | 279,778 |
| Yea Christopher | Chief Development Officer | 10/16/2020 | 15,539 |
| Feener Edward P. | Chief Scientific Officer | 10/16/2020 | 16,881 |
| Crockett Thomas Andrew | CEO | 10/16/2020 | 21,444 |
| Yea Christopher | Chief Development Officer | 02/05/2020 | 1,710 |
| Feener Edward P. | Chief Scientific Officer | 02/05/2020 | 1,711 |
| Crockett Thomas Andrew | CEO | 02/05/2020 | 3,410 |
| Yea Christopher | Chief Development Officer | 12/20/2019 | 11 |
| Yea Christopher | Chief Development Officer | 12/20/2019 | 45,025 |
| Crockett Thomas Andrew | CEO | 12/20/2019 | 39,150 |
| Yea Christopher | Chief Development Officer | 12/12/2019 | 1 |
| Yea Christopher | Chief Development Officer | 12/16/2019 | 13 |
| Yea Christopher | Chief Development Officer | 12/13/2019 | 6 |
| Yea Christopher | Chief Development Officer | 12/12/2019 | 3,383 |
| Yea Christopher | Chief Development Officer | 12/16/2019 | 51,318 |
| Yea Christopher | Chief Development Officer | 12/13/2019 | 25,568 |
| Crockett Thomas Andrew | CEO | 12/16/2019 | 92,116 |
| Crockett Thomas Andrew | CEO | 12/13/2019 | 37,536 |
| Crockett Thomas Andrew | CEO | 12/12/2019 | 1,700 |
| SOLAND DANIEL B | Director | 09/27/2019 | 94,498 |
| SOLAND DANIEL B | Director | 09/26/2019 | 24,252 |
| Cha Albert | Director | 07/29/2019 | 88,011 |
| Cha Albert | Director | 07/29/2019 | 423,692 |
| Cha Albert | Director | 07/26/2019 | 369,317 |
| Cha Albert | Director | 07/26/2019 | 76,718 |
| Yea Christopher | Chief Development Officer | 07/22/2019 | 32 |
| Yea Christopher | Chief Development Officer | 07/22/2019 | 134,930 |
| Feener Edward P. | Chief Scientific Officer | 07/23/2019 | 35,439 |
| Feener Edward P. | Chief Scientific Officer | 07/22/2019 | 26,004 |
| Cha Albert | Director | 07/19/2019 | 182,453 |
| Cha Albert | Director | 07/17/2019 | 3,724 |
| Cha Albert | Director | 07/17/2019 | 17,991 |
| Cha Albert | Director | 07/19/2019 | 886,127 |
| Crockett Thomas Andrew | CEO | 07/15/2019 | 170,407 |
| Yea Christopher | Chief Development Officer | 04/22/2019 | 32 |
| Yea Christopher | Chief Development Officer | 04/22/2019 | 191,530 |
| Crockett Thomas Andrew | CEO | 04/15/2019 | 247,958 |
| Palleiko Benjamin L | CBO, CFO and Secretary | 04/22/2019 | 16,780 |
| Palleiko Benjamin L | CBO, CFO and Secretary | 04/18/2019 | 7,232 |
| Palleiko Benjamin L | CBO, CFO and Secretary | 04/22/2019 | 51,603 |
| Palleiko Benjamin L | CBO, CFO and Secretary | 04/18/2019 | 27,373 |
| Feener Edward P. | Chief Scientific Officer | 04/17/2019 | 99,666 |
| SVLSF IV, LLC | 10% Owner | 04/10/2019 | 397,746 |
| SVLSF IV, LLC | 10% Owner | 04/09/2019 | 389,983 |
| SVLSF IV, LLC | 10% Owner | 04/08/2019 | 672,415 |
| Maetzel Andreas | Senior Vice President Medical | 04/05/2019 | 39,550 |
| Maetzel Andreas | Senior Vice President Medical | 04/05/2019 | 150,011 |
| SVLSF IV, LLC | 10% Owner | 04/02/2019 | 262,930 |
| SVLSF IV, LLC | 10% Owner | 04/01/2019 | 1,461,210 |
| SVLSF IV, LLC | 10% Owner | 03/29/2019 | 996,756 |
| SVLSF IV, LLC | 10% Owner | 03/27/2019 | 1,683,022 |
| SVLSF IV, LLC | 10% Owner | 03/26/2019 | 893,687 |
| SVLSF IV, LLC | 10% Owner | 03/28/2019 | 1,019,324 |
| SVLSF IV, LLC | 10% Owner | 03/18/2019 | 7,007,949 |
| Venrock Healthcare Capital Partners II, L.P. | 10% Owner | 03/18/2019 | 14,375,000 |
| Crockett Thomas Andrew | CEO | 03/14/2019 | 90,484 |
| SVLSF IV, LLC | 10% Owner | 03/04/2019 | 993,660 |
| SVLSF IV, LLC | 10% Owner | 03/05/2019 | 744,816 |
| SVLSF IV, LLC | 10% Owner | 02/21/2019 | 3,554,386 |
| SVLSF IV, LLC | 10% Owner | 02/20/2019 | 465,069 |
| SVLSF IV, LLC | 10% Owner | 02/19/2019 | 381,898 |
| Yea Christopher | Chief Development Officer | 01/25/2019 | 23 |
| Yea Christopher | Chief Development Officer | 01/25/2019 | 93,015 |
| Yea Christopher | Chief Development Officer | 01/23/2019 | 3 |
| Yea Christopher | Chief Development Officer | 01/22/2019 | 6 |
| Yea Christopher | Chief Development Officer | 01/23/2019 | 10,205 |
| Yea Christopher | Chief Development Officer | 01/22/2019 | 22,139 |
| Feener Edward P. | Chief Scientific Officer | 01/16/2019 | 78,210 |
| Crockett Thomas Andrew | CEO | 01/14/2019 | 193,328 |
| SVLSF IV, LLC | 10% Owner | 01/07/2019 | 53,051 |
| SVLSF IV, LLC | 10% Owner | 01/03/2019 | 34,022 |
| SVLSF IV, LLC | 10% Owner | 12/28/2018 | 74,781 |
| SVLSF IV, LLC | 10% Owner | 01/02/2019 | 4,000 |
| SVLSF IV, LLC | 10% Owner | 12/31/2018 | 508,462 |
| SVLSF IV, LLC | 10% Owner | 12/19/2018 | 42,758 |
| Feener Edward P. | Chief Scientific Officer | 09/18/2018 | 42,625 |
| ORONSKY ARNOLD L | Director | 09/10/2018 | 1,000,008 |
| Cha Albert | Director | 09/10/2018 | 18,000,008 |
| ALDRICH RICHARD | Director | 10/12/2017 | 4,866,961 |
| RA CAPITAL MANAGEMENT, LLC | Director | 10/12/2017 | 7,225,000 |
| Shah Rajeev M. | Director | 10/12/2017 | 7,225,000 |
| Novo Holdings A/S | 10% Owner | 10/10/2017 | 11,232,599 |
| Novo Holdings A/S | 10% Owner | 10/12/2017 | 14,675,820 |
| Novo Holdings A/S | 10% Owner | 10/11/2017 | 362,763 |
| Novo Holdings A/S | 10% Owner | 09/15/2017 | 985,841 |
| Novo Holdings A/S | 10% Owner | 09/14/2017 | 80,500 |
| Novo Holdings A/S | 10% Owner | 09/13/2017 | 207,614 |
| Novo Holdings A/S | 10% Owner | 09/13/2017 | 207,614 |
| Novo Holdings A/S | 10% Owner | 09/15/2017 | 985,865 |
| Novo Holdings A/S | 10% Owner | 09/14/2017 | 80,500 |
| Renzi David | President & CEO | 11/21/2016 | 287,477 |
| Renzi David | President & CEO | 11/21/2016 | 287,258 |
| Renzi David | President & CEO | 11/21/2016 | 27,378 |
| Basta Steven L | Director | 11/21/2016 | 8,817 |
| Basta Steven L | Director | 11/21/2016 | 8,820 |
| Basta Steven L | Director | 11/21/2016 | 851 |
| Maroney Marcee | VP, Clinical Affairs | 11/21/2016 | 36,564 |
| Maroney Marcee | VP, Clinical Affairs | 11/21/2016 | 36,566 |
| Maroney Marcee | VP, Clinical Affairs | 11/21/2016 | 3,515 |
| Renzi David | President & CEO | 12/30/2015 | 5,600 |
| Renzi David | President & CEO | 12/30/2015 | 37,000 |
| CHA ALBERT | Director | 04/14/2015 | 5,062,500 |
| Vivo Ventures VI, LLC | 10% Owner | 04/14/2015 | 5,062,500 |
| InterWest Management Partners IX, LLC | 10% Owner | 04/14/2015 | 4,050,000 |
| ACMP IV LLC | 10% Owner | 04/14/2015 | 4,387,500 |
| NOHRA GUY P | Director | 04/14/2015 | 4,387,500 |
| CHA ALBERT | Director | 04/14/2015 | 5,062,500 |
| Vivo Ventures VI, LLC | 10% Owner | 04/14/2015 | 5,062,500 |
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 01/31/2022
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
10/31/2021
0.06%
1Q
07/31/2021
0.08%
2Q
04/30/2021
28.05%
3Q
01/31/2021
36.55%
4Q
10/31/2020
36.76%
5Q
07/31/2020
36.98%
6Q
04/30/2020
37.76%
7Q
01/31/2020
38.00%
8Q
10/31/2019
38.48%
9Q
07/31/2019
39.80%
10Q
Load More